These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36607382)
1. Incidental Finding of a Tongue Schwannoma Mimicking Local Recurrence of Squamous Cell Carcinoma on a Systematic Follow-up 18F-FDG PET/CT. Dzuko Kamga J; Leclere JC; Conan-Charlet V; Tissot V; Abgral R Clin Nucl Med; 2023 Feb; 48(2):e92-e94. PubMed ID: 36607382 [TBL] [Abstract][Full Text] [Related]
2. Hepatic Schwannoma on 18F-FDG PET/CT. Liu Y; Xu B Clin Nucl Med; 2020 Oct; 45(10):808-810. PubMed ID: 32604115 [TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma of the tongue with cardiac metastasis on 18F-FDG PET/CT: A case report and literature review. Delabie P; Evrard D; Zouhry I; Ou P; Rouzet F; Benali K; Piekarski E Medicine (Baltimore); 2021 Apr; 100(15):e25529. PubMed ID: 33847677 [TBL] [Abstract][Full Text] [Related]
4. Value of [18F]FDG PET-CT in the follow-up of surgically treated oral tongue squamous cell carcinoma: single centre cohort analysis on 87 patients. Ravanelli M; Grammatica A; Squassina G; Bertagna F; Albano D; Lancini D; Bosio P; Zigliani A; Agazzi GM; Maroldi R; Nicolai P; Giubbini R; Piazza C; Farina D Nucl Med Rev Cent East Eur; 2021; 24(2):58-62. PubMed ID: 34382669 [TBL] [Abstract][Full Text] [Related]
5. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma. Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422 [TBL] [Abstract][Full Text] [Related]
6. An intrathoracic schwannoma case in Gültekin A; Aydoğmuş Ü; Arifoğlu H; Bir F; Yaylalı O Hell J Nucl Med; 2020; 23(2):206-208. PubMed ID: 32716413 [TBL] [Abstract][Full Text] [Related]
7. Porta Hepatic Schwannoma on FDG PET/CT. Filizoglu N; Oksuzoglu K; Ozguven S; Ones T; Erdil TY Clin Nucl Med; 2021 Jul; 46(7):575-576. PubMed ID: 33492856 [TBL] [Abstract][Full Text] [Related]
8. Post-Treatment Neck Dissection of Tonsillar and Base of Tongue Squamous Cell Carcinoma in the Era of PET-CT, HPV, and p16. Landin D; Näsman A; Jara SJ; Hammarstedt-Nordenvall L; Munck-Wikland E; Dalianis T; Marklund L Viruses; 2022 Jul; 14(8):. PubMed ID: 36016315 [TBL] [Abstract][Full Text] [Related]
9. 18 F-FDG PET/CT of Benign Tracheal Schwannoma. Lu KY; Cheng Y; Jiang ZP; Shao D; Wang SY Clin Nucl Med; 2024 Sep; 49(9):854-856. PubMed ID: 38968555 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822 [TBL] [Abstract][Full Text] [Related]
11. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
12. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? Abgral R; Querellou S; Potard G; Le Roux PY; Le Duc-Pennec A; Marianovski R; Pradier O; Bizais Y; Kraeber-Bodéré F; Salaun PY J Nucl Med; 2009 Jan; 50(1):24-9. PubMed ID: 19091901 [TBL] [Abstract][Full Text] [Related]
13. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up. Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809 [TBL] [Abstract][Full Text] [Related]
14. Retroperitoneal Recurrence of Melanotic Schwannoma on 18F-FDG PET/CT. OuYang X; Zheng L; Zhang X Clin Nucl Med; 2021 Dec; 46(12):991-993. PubMed ID: 34560691 [TBL] [Abstract][Full Text] [Related]
15. Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517 [TBL] [Abstract][Full Text] [Related]
16. Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible. Lopez R; Gantet P; Julian A; Hitzel A; Herbault-Barres B; Alshehri S; Payoux P J Craniomaxillofac Surg; 2018 May; 46(5):743-748. PubMed ID: 29567343 [TBL] [Abstract][Full Text] [Related]
17. FDG PET/CT in a Case With Cellular Schwannoma of the Kidney. Yu Z; Zhang J; Dong A; Zhu Y Clin Nucl Med; 2022 Nov; 47(11):996-997. PubMed ID: 35619199 [TBL] [Abstract][Full Text] [Related]
18. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. Fischbein NJ; AAssar OS; Caputo GR; Kaplan MJ; Singer MI; Price DC; Dillon WP; Hawkins RA AJNR Am J Neuroradiol; 1998 Aug; 19(7):1189-96. PubMed ID: 9726451 [TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT imaging for aggressive melanotic schwannoma of the L3 spinal root: A case report. Shen XZ; Wang W; Luo ZY Medicine (Baltimore); 2021 Feb; 100(8):e24803. PubMed ID: 33663098 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography. Li P; Zhuang H; Mozley PD; Denittis A; Yeh D; Machtay M; Smith R; Alavi A Clin Nucl Med; 2001 Feb; 26(2):131-5. PubMed ID: 11201470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]